Compare · head to head
Kissei Pharmaceutical vs Reyon Pharmaceutical
Kissei Pharmaceutical ranks higher overall — 360 rank 62 vs 16.
Kissei Pharmaceutical leads on Value (61 vs 44), Growth (47 vs 42) and Safety (69 vs 33). Reyon Pharmaceutical leads on Sentiment (48 vs 41). The two are close on Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Medium | Small |
| ISIN | JP3240600001 | KR7102460003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 62 | 16 |
| Value | 61 | 44 |
| Quality | 43 | 43 |
| Growth | 47 | 42 |
| Safety | 69 | 33 |
| Sentiment | 41 | 48 |
| Quality details | ||
| Profitability | 40 | 37 |
| Cash Truth | 46 | 50 |
Kissei Pharmaceutical vs HUTCHMED (China)Kissei Pharmaceutical vs YuhanKissei Pharmaceutical vs Kyongbo PharmaceuticalKissei Pharmaceutical vs Bora PharmaceuticalsAdd a third stock →
Full analyses: Kissei Pharmaceutical · Reyon Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100